Toward a new autoantibody diagnostic orthodoxy: Understanding the bad, good and indifferent

Autoimmunity Highlights

Volumn 3, Issue 2, 2012, Pages 51-58

  Fritzler, Marvin J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti nuclear antibodies; Autoantibodies; Autoantigens; Diagnostics

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; CARDIOLIPIN; CHOLINERGIC RECEPTOR ANTIBODY; DNA ANTIBODY;

ANTIBODY DETECTION; ANTIGEN BINDING; ATTITUDE TO HEALTH; BLOOD ANALYSIS; COMPLEMENT FIXATION TEST; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENOMICS; GOLD STANDARD; HEMAGGLUTINATION TEST; HUMAN; IMMUNOASSAY; IMMUNODIFFUSION; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOGENESIS; INFORMATION DISSEMINATION; LUPUS ERYTHEMATOSUS; MEDICAL INFORMATION; METABOLOMICS; MYASTHENIA GRAVIS; MYELITIS; MYELOOPTIC NEUROPATHY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROGNOSIS; PROTEIN FUNCTION; PROTEOMICS; REVIEW; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; TURNAROUND TIME; VENEREAL DISEASE REACTION TEST;

EID: 84864486678     PISSN: 20380305     EISSN: 20383274     Source Type: Journal    
DOI: 10.1007/s13317-012-0030-7     Document Type: Review

References (91)

1. Ehrlich P (1900) On immunity with special reference to cell life. Proc R Soc Lond 66: 424-448.
2. Wassermann VA, Neisser A, Bruck C (1906) Eine serodiagnostische reaktion bei syphilis. Deutsche Medicinische Wochenshrift 19: 745-746.
3. Moore JE, Mohr CF (1952) Biologically false positive serologic tests for syphilis. J Am Med Assoc 150: 467-473.
4. Tuffanelli DL (1968) False-positive reactions for syphilis. Serological abnormalities in relatives of chronic reactors. Arch Derm 98: 606-611.
5. Koike T, Sueishi M, Funaki H, Tomioka H, Yoshida S (1984) Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 56: 193-199.
6. Conrad K, Schlosser W, Hiepe F, Fritzler MJ (2011) Autoantibodies in organ specific autoimmune diseases: a diagnostic reference. Pabst Science, Lengerich.
7. Hargraves MM, Richmond H, Morton R (1948) Presentation of two bone marrow elements: the "tart" cells and the "L. E." cell. Mayo Clin Proc 23: 25-28.
8. Conn RB (1994) Practice parameter: the lupus erythematosus cell test. Am J Clin Pathol 101: 65-66.
9. Fritzler MJ (1986) Autoantibody testing: procedures and significance in systemic rheumatic diseases. Meth Achiev Exp Pathol 12: 224-260.
10. Warde N (2011) Connective tissue diseases: agonistic autoantibodies: do they have a role in the pathophysiology of SSc? Nat Rev Rheumatol 7: 71.
11. Weller T, Coons AH (1954) Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med 86: 789-794.
12. Fritzler MJ, Wiik A (2006) Autoantibody assays, testing, and standardization. In: Rose NR, Mackay IR (eds) The autoimmune diseases, 4th edn. Elsevier Academic Press, Sydney, pp 1011-1022.
13. Holborow EJ, Weir DM, Johnson GD (1957) A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J 2: 732-734.
14. Hijmans W, Schuit HRE, Mandema E et al (1964) Comparative study for the detection of antinuclear factors with the fluorescent antibody technique. Ann Rheum Dis 23: 73-77.
15. Kunkel HG, Tan EM (1964) Autoantibodies and disease. Adv Immunol 4: 351-372.
16. Beck JS (1961) Variations in the morphological patterns of "autoimmune" nuclear fluorescence. Lancet 1: 1203-1207.
17. Nakamura RM, Tan EM (1977) Recent progress in the study of autoantibodies to nuclear antigens. Human Pathol 9: 85-91.
18. Nakamura RM, Peebles CL, Molden DP, Tan EM (1984) Advances in laboratory tests for autoantibodies to nuclear antigens in systemic rheumatic diseases. Lab Med 15: 190-198.
19. Lucey BP, Nelson-Rees WA, Hutchins GM (2009) Henrietta Lacks, HeLa cells, and cell culture contamination. Arch Pathol Lab Med 133: 1463-1467.
20. Nelson-Rees WA, Daniels DW, Flandermeyer RR (1981) Cross-contamination of cells in culture. Science 212: 446-452.
21. Tan EM, Feltkamp TEW, Smolen JS et al (1997) Range of antinuclear antibodies in "healthy individuals. Arthr Rheum 40: 1601-1611.
22. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus. Semin Arthr Rheum 34: 501-537.
23. Sherer Y, Shoenfeld Y (2007) Autoantibody explosion in lupus-155 different autoantibodies in SLE. Lupus 16(suppl): 42.
24. Walker JG, Fritzler MJ (2007) Update on autoantibodies in systemic sclerosis. Curr Opin Rheumatol 19: 580-591.
25. Mahler M, Silverman ED, Fritzler M (2010) Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods. Lupus 19: 1527-1533.
26. Fritzler MJ, Rattner JB, Luft LM et al (2010) Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Autoimmun Rev 10: 194-200.
27. Reimer G, Raska I, Tan EM, Scheer U (1987) Human autoantibodies: probes for nucleolus structure and function. Virchows Arch B 54: 131-143.
28. Welting TJ, Raijmakers R, Pruijn GJ (2003) Autoantigenicity of nucleolar complexes. Autoimmun Rev 2: 313-321.
29. Enarson P, Rattner JB, Ou Y, Miyachi K, Horigome T, Fritzler MJ (2004) Autoantigens of the nuclear pore complex. J Mol Med 82: 423-433.
30. Fritzler MJ, Stinton LM, Chan EKL (2007) Autoantibodies to cytoplasmic autoantigens in endosomes, exosomes and the Golgi complex. In: Conrad K, Chan EKL, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A (eds) From etiopathogenesis to the prediction of autoimmune diseases: relevance of autoantibodies, 5th edn. Pabst Science, Lengerich, pp 194-209.
31. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44: 93-151.
32. Halbert SP, Karsh J, Anken M (1981) Studies on autoantibodies to deoxyribonucleic acid and deoxyribonucleoprotein with enzyme-immunoassay (ELISA). J Lab Clin Med 97: 97-111.
33. Reichlin M, Harley JB (1986) Detection by ELISA of antibodies to small RNA protein particles in SLE patients whose sera lack precipitins. Trans Assoc Am Phys 99: 161-171.
34. Tonutti E, Bassetti D, Piazza A et al (2004) Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 37: 171-176.
35. Stott DI (1989) Immunoblotting and dot blotting. J Immunol Methods 119: 153-187.
36. Nezlin R, Mozes E (1995) Detection of antigens in immune complexes by a dot blot assay. J Immunol Methods 184: 273-276.
37. Damoiseaux J, Boesten K, Giesen J, Austen J, Tervaert JW (2005) Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann NY Acad Sci 1050: 340-347.
38. Pottel H, Wiik A, Locht H et al (2004) Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies in connective tissue disorders. Clin Exp Rheumatol 22: 579-588.
39. Fritzler MJ (2006) Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 15: 422-427.
40. Fritzler MJ, Fritzler ML (2009) Microbead-based technologies in diagnostic autoantibody detection. Expert Opin Med Diagn 3: 81-89.
41. Baker CA, Lu ZY, Manuelidis L (2004) Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease. J Neurovirol 10: 29-40.
42. Balboni I, Limb C, Tenenbaum JD, Utz PJ (2008) Evaluation of microarray surfaces and arraying parameters for autoantibody profiling. Proteomics 8: 3443-3449.
43. Chandra PE, Sokolove J, Hipp BG et al (2011) Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthr Res Ther 13: R102.
44. Freeman RG, Raju PA, Norton SM et al (2005) Use of nanobarcodes particles in bioassays. Methods Mol Biol 303: 73-83.
45. Mahler M, Radice A, Sinico RA et al (2011) Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrol Dial Transplant 27: 243-252.
46. Fritzler MJ (2011) The antinuclear antibody (ANA) test: last or lasting gasp? Arthr Rheum 16: 19-22.
47. Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69: 1420-1422.
48. American College of Rheumatology (2011) Position paper: methodology of testing for antinuclear antibodies.
49. Hoffman IE, Peene I, Veys EM, De KF (2002) Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem 48: 2171-2176.
50. Mahler M, Kessenbrock K, Raats J, Fritzler MJ (2004) Technical and clinical evaluation of anti-ribosomal P protein immunoassays. J Clin Lab Anal 18: 215-223.
51. Mahler M, Ngo J, Schulte-Pelkum J, Luettich T, Fritzler MJ (2008) Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies. Arthr Res Ther 10: R131.
52. Stinton LM, Swain M, Myers RP, Shaheen AA, Fritzler MJ (2010) Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin Exp Immunol 163: 147-156.
53. Mahler M, Fritzler MJ (2009) The changing landscape of the clinical value of the PM/Scl autoantibody system. Arthr Res Ther 11: 106.
54. Elkon K, Casali P (2008) Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 4: 491-498.
55. de Baets MH (2010) Insights in the autoimmunity of myasthenia gravis. Autoimmunity 43: 341-343.
56. Saikali P, Cayrol R, Vincent T (2009) Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica. Autoimmun Rev 9: 132-135.
57. Cayrol R, Saikali P, Vincent T (2009) Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica. Ann NY Acad Sci 1173: 478-486.
58. Benavente E, Paira S (2011) Neuromyelitis Optica-AQP4: an update. Curr Rheumatol Rep 13: 496-505.
59. Mackay IR, Leskovsek NV, Rose NR (2008) Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30: 5-11.
60. van der Vlag J, Berden JH (2011) Lupus nephritis: role of antinucleosome autoantibodies. Semin Nephrol 31: 376-389.
61. Scheinecker C, Bonelli M, Smolen JS (2010) Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun 35: 269-275.
62. Faust TW, Chang EH, Kowal C et al (2010) Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci USA 107: 18569-18574.
63. Tan FK (2006) Autoantibodies against PDGF receptor in scleroderma. N Engl J Med 354: 2709-2711.
64. Gabrielli A, Svegliati S, Moroncini G, Luchetti M, Tonnini C, Avvedimento EV (2007) Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets. Autoimmun Rev 7: 121-126.
65. Shoenfeld Y, Toubi E (2005) Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthr Rheum 52: 2599-2606.
66. Meroni PL, Shoenfeld Y (2008) Predictive, protective, orphan autoantibodies: the example of the anti-phospholipid antibodies. Autoimmun Rev 7: 585-587.
67. Toubi E, Shoenfeld Y (2007) Protective autoimmunity in cancer (Review). Oncol Rep 17: 245-251.
68. Jennette JC, Falk RJ (2010) The rise and fall of horror autotoxicus and forbidden clones. Kidney Int 78: 533-535.
69. Casadevall A, Pirofski LA (2011) A new synthesis for antibody-mediated immunity. Nat Immunol 13: 21-28.
70. Cui Z, Zhao MH, Segelmark M, Hellmark T (2010) Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int 78: 590-597.
71. Jennette JC (2011) Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener's granulomatosis). Clin Exp Immunol 164(Suppl 1): 7-10.
72. Biron CA, Casadevall A (2010) On immunologists and microbiologists: ground zero in the battle for interdisciplinary knowledge. MBio 1. (pii: e00260-10).
73. Walker UA, Tyndall A, Czirjak L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis-a report from the EULAR scleroderma trials and research (EUSTAR) group data base. Ann Rheum Dis 66: 754-763.
74. Ching KH, Burbelo PD, Tipton C et al (2012) Two major autoantibody clusters in systemic lupus erythematosus. PLoS ONE 7: e32001.
75. Fritzler MJ (2011) Personalized medicine approaches in rheumatoid arthritis and other systemic autoimmune rheumatic diseases. In: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Shoenfeld Y (eds) From prediction to prevention of autoimmune diseases. Pabst Science, Berlin, pp 127-137.
76. Pirofski LA, Casadevall A (2012) Q and A what is a pathogen? A question that begs the point. BMC Biol 10: 6.
77. Nirula A, Glaser SM, Kalled SL, Taylor FR (2011) What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 23: 119-124.
78. Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366: 539-551.
79. Dubois-Galopin F, Beauvillain C, Dubois D et al (2007) New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies. Ann Rheum Dis 66: 1121-1122.
80. Schnaidt M, Weinstock C, Jurisic M, Schmid-Horch B, Ender A, Wernet D (2011) HLA antibody specification using single-antigen beads-a technical solution for the prozone effect. Transplantation 92: 510-515.
81. Wang Q, Rozelle AL, Lepus CM et al (2011) Identification of a central role for complement in osteoarthritis. Nat Med 17: 1674-1679.
82. Kallenberg CG (2011) Pathogenesis of ANCA-associated vasculitis, an update. Clin Rev Allergy Immunol 41: 224-231.
83. Tradtrantip L, Zhang H, Anderson MO et al (2012) Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J.
84. Tu Z, Li Q, Chou HS et al (2011) Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology 216: 528-534.
85. Torres M, Casadevall A (2008) The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol 29: 91-97.
86. van Venrooij WJ, van Beers JJ, Pruijn GJ (2011) Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 7: 391-398.
87. Astle JM, Simpson LS, Huang Y et al (2010) Seamless bead to microarray screening: rapid identification of the highest affinity protein ligands from large combinatorial libraries. Chem Biol 17: 38-45.
88. Ullal AJ, Reich CF III, Clowse M et al (2011) Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun 36: 173-180.
89. Pisetsky DS (2012) Microparticles as autoantigens: making immune complexes big. Arthr Rheum.
90. Lindstrom TM, Robinson WH (2011) Fishing for biomarkers with antigen mimics. Cell 144: 13-15.
91. Reddy MM, Wilson R, Wilson J et al (2011) Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening. Cell 144: 132-142.